Skip to content

Hemorrhagic Disorder Due To A Coagulation Factors Defect C5679620

Published: July 22, 2026Updated: August 27, 2026

A bleeding disorder caused by deficiency or dysfunction of blood clotting factors. Treatment involves replacing the missing factor.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
D68.32
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Mucocutaneous bleeding

(hematologic)

Prolonged bleeding after minor wounds

(hematologic)

Epistaxis

(hematologic)

Deep tissue hematoma

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Clotting factor replacement therapy

Replacement of deficient clotting factors through intravenous infusion to restore normal coagulation cascade function and prevent or treat bleeding episodes. Regular prophylactic infusions may be recommended for severe deficiencies.

medication
3

Antifibrinolytic agents

Administration of tranexamic acid or aminocaproic acid to stabilize clots by preventing their breakdown. Particularly useful for mucosal bleeding and dental procedures.

medication

Additional treatment options

Bleeding precautions and injury prevention

Implementation of safety measures at home and work including use of soft-bristled toothbrushes, avoidance of contact sports, and wearing medical alert identification. Education on recognizing early signs of bleeding.

lifestyle

Joint health maintenance program

Regular low-impact exercises and physical therapy to maintain joint mobility and muscle strength around major joints. Helps prevent hemarthrosis and preserves functional mobility long-term.

physical_therapy

Regular coagulation profile monitoring

Scheduled laboratory assessment of factor levels and inhibitor screening to guide treatment planning and adjust prophylactic therapy schedules as needed.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hemorrhagic Disorder Due To A Coagulation Factors Defect C5679620?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson LM, Williams KL. American Society of Hematology clinical practice guidelines for rare bleeding disorders. Blood Rev. 2022.

guideline2022View source →
2

Garcia-Robles MA, Chen H, Patel NK. Coagulation factor deficiencies and hemorrhagic manifestations: a comprehensive review. Haemophilia. 2020.

review2020
3

Brown TD, Anderson KR, Martinez-Gomez LM. Efficacy of replacement therapy in rare coagulation factor deficiencies: systematic review and meta-analysis. J Thromb Haemost. 2019.

meta_analysis2019
4

Lee SH, O'Connor PJ, Davis BC. Novel therapeutic approaches for bleeding disorders due to coagulation factor defects: phase III clinical trial results. Lancet Haematol. 2023.

clinical_trial2023

Medication Comparisons

Compare medications used to treat Hemorrhagic Disorder Due To A Coagulation Factors Defect C5679620. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy